Better Context Better Decisions

Context counts in life sciences. The Celltelligence analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access can use our library to search all of the content already delivered to their inbox. If you think a colleague would enjoy receiving our content, reach out to the Celltelligence team to make it happen.

Free
Posted in: Autologous, CAR-T, CD19 Jan 23 | 2023Breyanzi Absent from January’s CHMP AgendaAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T, TCR Jan 20 | 2023Thoughts on AstraZeneca's Cell Therapy PipelineAccess Free Blast
Free
Posted in: Allogeneic, Autologous, BCMA, CAR-T, CD19, CD22 Jan 13 | 2023JPM 2023 Analysis Day 4: Autolus and Caribou BiosciencesAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T Jan 12 | 2023JPM 2023 Analysis Day 3: Century Tx, Atara Bio, and PrecigenAccess Free Blast
Free
Posted in: Autologous, BCMA, CAR-T, CD19 Jan 10 | 2023JPM 2023 Analysis Day 1: BMS, Novartis, JNJ, and GileadAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T, CD19, TCR Jan 09 | 2023We're Back! Holiday Recap Ahead of JPM 2023Access Free Blast
Free
Posted in: Allogeneic, Autologous, BCMA, CAR-T, CD123, CD19 Dec 19 | 2022You May Have Missed: ASH 2022 AnalysesAccess Free Blast
1 2 3 22

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.